Private Advisor Group, LLC Corcept Therapeutics Inc Transaction History

Private Advisor Group, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Apr 01, 2021	SELL	$16.78 - $27.3 $184,764 - $300,600	-11,011 Closed	0 $0
Q2 2020 Aug 17, 2020	SELL	$11.0 - $18.26 $120,879 - $200,659	-10,989 Reduced 49.95%	11,011 $185,000
Q1 2020 May 12, 2020	SELL	$10.11 - $14.04 $30,330 - $42,120	-3,000 Reduced 12.0%	22,000 $262,000
Q4 2019 Feb 10, 2020	BUY	$12.06 - $16.96 $301,500 - $424,000	25,000 New	25,000 $303,000

347

86.6M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $6.3B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Private Advisor Group, LLC with notifications on news.